Primate Studies Raise Hope of Eventual Quarterly Injected PrEP
Researchers from two primate studies reached conclusions that quarterly injected PrEP (four times a year) may one day become a reality for humans.
New HIV Treatment, Antiretroviral Cabotegravir, Lasts For Three Months
Today, HIV infections are completely treatable thanks to antiretroviral medication. Only problem is these drugs must be taken on a regular basis for them to remain effective, and for many HIV-positive individuals throughout the world, this simply isn’t possible. A new antiretroviral drug called cabotegravir, however, may solve this widespread problem, since it only requires injection once every three months.
A possible HIV vaccine in the form of a pill?
Researchers at the University of Rochester Medical Center are testing a new oral vaccine to prevent infection with HIV, the virus that causes AIDS. The vaccine is unique because it is given as a pill, unlike most HIV vaccines tested to date that have been given as shots.
Scientists train immune system to spot and destroy cure-defying mutant HIV
Luring dormant HIV out of hiding and destroying its last cure-defying holdouts has become the holy grail of HIV eradication, but several recent attempts to do so have failed. Now the findings of a Johns Hopkins-led study reveal why that is and offer a strategy that could form a blueprint for a therapeutic vaccine to eradicate lingering virus from the body.
The surprising link between HIV and hearing loss
Adults who are HIV-positive are more likely to experience hearing loss than adults who do not have HIV, according to research published online December 26 in JAMA-Otolaryngology-Head & Neck Surgery. Researchers report that adults with HIV were more likely to experience difficulty hearing both high and low tones, regardless of the severity of HIV disease progression or the use of and adherence to HIV medications. Funded by the National Institutes of Health (NIH), the new findings expand upon earlier research that has suggested an increased risk of hearing loss in adults with HIV.
"And…Cut! A double circumcision story" by Anonymous
And…Cut! (A double circumcision story)
Circumcision is a controversial topic. Pros and cons exist for men who are cut, and men who are not. In 2007, I decided to get cut. I had a number of reasons, amongst them that I prefer the way cut dicks look, personal hygiene, and that I’d heard that I would have 60% less chance of contracting HIV, should I ever have unprotected sex.
"The Red Ribbon" by Joe Lean
Ground breaking website launched in Africa for men who have sex with men
Men who have sex with men (MSM) living in East Africa, where homophobia is on the rise, now have access to a unique website, Afya4Men.info, which contains comprehensive sexual health information targeted to their specific needs.
